UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008624
Receipt number R000010135
Scientific Title Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens
Date of disclosure of the study information 2012/08/05
Last modified on 2018/01/08 19:37:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens

Acronym

Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens

Scientific Title

Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens

Scientific Title:Acronym

Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens

Region

Japan


Condition

Condition

Gastric Cancer

Classification by specialty

Surgery in general Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the study is to evaluate the efficacy of methylene blue-assisted lymph node technique for LN assessment in gastric cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

the ratio of the number of the harvested lymph nodes per time (minute)

Key secondary outcomes

the number of harvested lymph nodes


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

(i) Histologically proven adenocarcinoma of the stomach.
(ii) Clinical stage1-3 disease.
(iii) R0 resection is acieved by gastrectomy with D1+ or D2 lymphadenectomy.

Key exclusion criteria

(i) Patients received any treatment before surgery.
(ii) Clinical Stage 4 disease.

Target sample size

56


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshikawa Takaki

Organization

Kanagawa Cancer Center

Division name

Department of Gastrointestinal Surgery

Zip code


Address

1-1-2 Nakao, Asahi-ku, Yokohama, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kanagawa Cancer Center

Division name

Department of Gastrointestinal Surgery

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Department of Gastrointestinal Surgery, Kanagawa Cancer Center

Institute

Department

Personal name



Funding Source

Organization

the Non-Governmental Organizations Kanagawa Standard Anti-cancer Therapy Support System

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 05 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The accrual was started in June 2012 and is to continue for 1 year.


Management information

Registered date

2012 Year 08 Month 05 Day

Last modified on

2018 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010135


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name